Sign in

AIIMS doctor says proper hygiene necessary to prevent mucormycosis. All you need to know about fungal infection

The fungal infection mainly affects people who are on medication for other health complexities that impair the ability to fight environmental pathogens, according to the Indian Medical Council of Medical Research (ICMR).

Updated on: May 12, 2021 6:45 PM IST
By | Written by | Edited by , Hindustan Times, New Delhi
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

The fungal infection mucormycosis, which is affecting many Covid-19 patients, is a growing concern in India. Dr Sanjeev Sinha, from All India Medical Institute of Medical Sciences (AIIMS) in Delhi, emphasised the need to maintain proper hygiene to prevent the infection. He also said that it is a curable disease, reported news agency ANI on Wednesday.

Representational: According to ICMR, mucormycosis can be suspected in Covid-19 patients - including diabetics or immunosuppressed individuals. (PTI PHOTO.)
Representational: According to ICMR, mucormycosis can be suspected in Covid-19 patients - including diabetics or immunosuppressed individuals. (PTI PHOTO.)

"We have to maintain proper hygiene to prevent mucormycosis. Immunosuppressant patients and those who use steroids for long time have to take extra precautions. It is a treatable disease," ANI quoted Dr Sinha as saying.

Also read| 'Should we laugh or cry': Akhilesh Yadav on use of cow dung in Covid-19 fight

The fungal infection mainly affects people who are on medication for other health complexities that impair the ability to fight environmental pathogens, according to the Indian Medical Council of Medical Research (ICMR). The inhalation of fungal spores from the air affects the lungs and sinuses of such individuals, the ICMR further said.

The research body has also described the symptoms of mucormycosis or black fungus which include pain and redness around the eyes and/or nose, fever, headache, coughing, shortness of breath, bloody vomits and altered mental status.

Also read: Cases of Covid-linked mucormycosis reported across India

According to ICMR, mucormycosis can be suspected in Covid-19 patients - including diabetics or immunosuppressed - when there is nasal blockage or congestion, blackish/bloody nasal discharge, and local pain on the cheekbone. It is also suspected if there is blurred or double vision with pain, fever, or skin lesion, thrombosis & necrosis (eschar), chest pain, pleural effusion, hemoptysis, worsening of respiratory symptoms, as per the ICMR.

In order to spread awareness around the disease, the government also released a set of instructions to follow the prevent infections. Here are the dos and don'ts to reduce the risk of infections, as released by the ICMR:

Dos:

Control hyperglycemia

Monitor blood glucose level post-Covid-19 discharge and in patients with diabetes

Use steroids judiciously. Timing, doses and duration should be correct

Use clean, sterile water for humidifiers during oxygen therapy

Use antibiotic or antifungals judiciously

Don’ts:

Miss warning signs and symptoms

Consider all the cases with a blocked nose as cases of bacterial sinusitis, particularly in the context of immunosuppression and/or Covid-19 patients on immunomodulators

Hesitate to seek aggressive investigations, as appropriate (KOH staining & microscopy, culture, MALDI-TOF), for detecting fungal etiology

Lose crucial time to initiate treatment for mucormycosis

Check India news real-time updates, latest news from India, latest India vs England LIVE Score, at HindustanTime